Preferred Label : CRISPR/Cas9-edited HPV16/18 E6/E7 Plasmid;
NCIt synonyms : CRISPR/Cas9 targeting HPV16/18 E6 and E7 Genes; CRISPR/Cas9-HPV16 E6/E7T1 Plus CRISPR/Cas9-HPV18 E6/ E7T2;
NCIt definition : A plasmid encoding for clustered regularly interspaced short palindromic repeats (CRISPR)
targeting the promoters for the human papillomavirus (HPV) type 16 (HPV16) and 18
(HPV18) epitopes E6 and E7, and coupled to the endonuclease cas9, with potential antineoplastic
activities. Upon administration and transfection of the CRISPR/Cas9-edited HPV16/18
E6/E7 plasmid, the guide RNA (gRNA) of the CRISPR moiety specifically targets and
binds to complementary sites on the HPV 16/18 promoter regions for E6 and E7. Cas9
cleaves these specific DNA sites, thereby disrupting HPV16/18 E6/E7 transcription.
Decreased expression of E6 and E7 induces apoptosis and decreases tumor cell proliferation
in HPV-driven tumor cells. This induces the expression of certain tumor suppressor
genes, such as p53 and retinoblastoma 1 (RB1), which induces tumor cell apoptosis
and inhibits tumor cell proliferation.;
NCI Metathesaurus CUI : CL550764;
Origin ID : C148185;
UMLS CUI : C4724882;
Semantic type(s)
- concept_is_in_subset
